< Back to previous page
Researcher
Arthur Van Aerschot
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Bioinformatics and computational biology
Affiliations
- Medicinal Chemistry (Rega Institute) (Division)
Member
From1 Oct 1999 → 30 Sep 2022
Projects
1 - 10 of 19
- Crystallographic facility for target-based drug designFrom1 May 2020 → TodayFunding: FWO International research infrastructure (IRI)
- Development of new antimicrobials: Rational design of polyomavirus and mycobacterial inhibitorsFrom1 Oct 2019 → 23 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a comprehensive platform for targeting redox homeostasis in Mycobacterium tuberculosis.From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Structure-guided design and development of antivirals targeting BK polyomavirus capsidFrom1 Oct 2018 → 30 Sep 2023Funding: IOF - Industrial Research Fund, Fund Recuperation Fiscal Exemption, BOF - Concerted Research Project from 1994
- Tyrosine-tRNA synthetase as target for the development of new antibacterial lead structuresFrom1 Sep 2018 → 1 Sep 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- In vivo molecular ion channel imaging.From1 May 2018 → 30 Sep 2022Funding: FWO Odysseus
- Structure-based design of new antitubercular medicinesFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Bilateral scientific cooperation
- Structural Characterization of Aminoacyl-tRNA Synthetase Inhibitors as Antibiotics and Tools for Enzyme Mechanistic StudiesFrom1 Oct 2016 → 23 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- High throughput analysis of biomolecular interactionsFrom1 May 2016 → 30 Apr 2020Funding: FWO Medium Size Research Infrastructure
- Synthesis and biological evaluation of albomycin and aminoacyl sulfonamide analogues as potential aaRS inhibitors.From1 Oct 2015 → 30 Sep 2018Funding: FWO fellowships
Publications
31 - 40 of 98
- Phytochemical and antidiabetic evaluation of the methanolic stem bark extract of Spathodea campanulata (P.Beauv.) Bignoniaceae(2016)
Authors: Arthur Van Aerschot, Gert Laekeman
Pages: 243 - 249 - Oligonucleotides containing a ribo-configured cyclohexanyl nucleoside: probing the role of sugar conformation in base pairing selectivity(2015)
Authors: Arthur Van Aerschot, Piet Herdewyn
Pages: 10041 - 10049 - 1',5'-Anhydro-l-ribo-hexitol Adenine Nucleic Acids (α-l-HNA-A): Synthesis and Chiral Selection Properties in the Mirror Image World(2015)
Authors: Mathy Froeyen, Arthur Van Aerschot, Piet Herdewyn
Pages: 5014 - 5022 - N-Acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR(2015)
Authors: Bharat Gadakh, Jenny Pouyez, Johan Wouters, Akkaladevi Venkatesham, Paul Cos, Arthur Van Aerschot
Pages: 1577 - 9 - N-Acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR(2015)
Authors: Bharat Gadakh, Arthur Van Aerschot
Pages: 1577 - 1579 - 5'-(N-aminoacyl)-sulfonamido-5'-deoxyadenosine: Attempts for a stable alternative for aminoacyl-sulfamoyl adenosines as aaRS inhibitors(2015)
Authors: Bharat Gadakh, Jef Rozenski, Mathy Froeyen, Arthur Van Aerschot
Pages: 227 - 236 - 5'-(N-aminoacyl)-sulfonamido-5'-deoxyadenosine: Attempts for a stable alternative for aminoacyl-sulfamoyl adenosines as aaRS inhibitors(2015)
Authors: Bharat Gadakh, Simon Smaers, Jef Rozenski, Mathy Froeyen, Arthur Van Aerschot
Pages: 227 - 36 - Renaissance in antibiotic discovery: some novel approaches for finding drugs to treat bad bugs(2015)
Authors: Bharat Gadakh, Arthur Van Aerschot
Pages: 2140 - 2158 - Renaissance in antibiotic discovery: some novel approaches for finding drugs to treat bad bugs(2015)
Authors: Bharat Gadakh, Arthur Van Aerschot
Pages: 2140 - 2158 - Hybridisation Potential of 1',3'-Di-O-methylaltropyranoside Nucleic Acids(2015)
Authors: Jef Rozenski, Mathy Froeyen, Arthur Van Aerschot
Pages: 4020 - 4041